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Ana Andres e, Renata M.C. Ariëns f, Shanna Bastiaan-Net f, Claire Bourlieu-Lacanal g,h, 
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f Wageningen Food & Biobased Research, Wageningen University and Research, 6708 WG Wageningen, the Netherlands 
g STLO Science et Technologie du Lait et de l’oeuf, INRAE – Institut Agro, 35000 Rennes, France 
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A B S T R A C T   
In vitro digestion studies often use animal digestive enzyme extracts as substitutes of human gastric and 
pancreatic secretions. Pancreatin from porcine origin is thus commonly used to provide relevant pancreatic 
enzymes such as proteases, amylase and lipase. Rabbit gastric extracts (RGE) have been recently introduced to 
provide gastric lipase in addition to pepsin. Before preparing simulated gastric and pancreatic extracts with 
targeted enzyme activities as described in in vitro digestion protocols, it is important to determine the activities of 
enzyme preparations using validated methods. The purpose of this inter-laboratory study within the INFOGEST 
network was to test the repeatability and reproducibility of lipase assays using the pH-stat technique for 
measuring the activities of gastric and pancreatic lipases from various sources. Twenty-one laboratories having 
different pH-stat devices received the same protocol with identical batches of RGE and two pancreatin sources. 
Lipase assays were performed using tributyrin as a substrate and three different amounts (50, 100 and 200 µg) of 
each enzyme preparation. The repeatability results within individual laboratories were satisfactory with co-
efficients of variation (CVs) ranging from 4 to 8% regardless of the enzyme amount tested. However, the inter- 
laboratory variability was high (CV > 15%) compared to existing standards for bioanalytical assays. We iden-
tified and weighted the contributions to inter-laboratory variability of several parameters associated with the 
various pH-stat equipment used in this study (e.g. reaction vessel volume and shape, stirring mode and rate, 
burette volume for the automated delivery of sodium hydroxide). Based on this, we established recommendations 
for improving the reproducibility of lipase assays using the pH-stat technique. Defining accurate and complete 
recommendations on how to correctly quantify activity levels of enzyme preparations is a gateway to promising 
comparison of in vitro data obtained from different laboratories following the same in vitro digestion protocol.   
1. Introduction 
In vitro models simulating gastrointestinal (GI) digestion are widely 
used as a tool to study, under well-controlled conditions, a wide range of 
food items without the constraints associated with human trials, e.g. 
ethics, cost, time, toxicity, limitation in the number of food products that 
can be tested or samples that can be collected, issues on variation among 
individuals (Hur, Lim, Decker, & McClements, 2011; Guerra et al., 2012; 
Minekus et al., 2014; Bornhorst, Gouseti, Wickham, & Bakalis, 2016). In 
vitro digestion models are based on the use of digestive enzyme prepa-
rations, often from animal sources, as substitutes of salivary, gastric and 
pancreatic secretions. Pancreatin from porcine origin is most commonly 
used to provide relevant pancreatic enzymes such as proteases, amylase 
and lipases (PL), while human salivary α-amylase can be used for pre-
paring simulated salivary fluid (Minekus et al., 2014). More recently, 
rabbit gastric extract (RGE) has been introduced to provide gastric lipase 
(GL) in addition to pepsin in simulated gastric fluid (Brodkorb et al., 
2019). Prior to performing in vitro digestion experiments, it is essential 
to assess the activities of these enzyme preparations in order to use 
enzyme concentrations that mimic physiological conditions, are 
consistent between experiments and enable comparison. With that in 
mind, standard protocols have been established based on in vivo data 
collected during the digestion of test meals, especially within the 
INFOGEST network, an international and multidisciplinary consortium 
of researchers from more than 35 countries (http://www.cost-infogest. 
eu). Within INFOGEST, a subgroup (WG4) is collaborating and sharing 
expertise in the field of lipid digestion phenomena and digestive lipases. 
One of its main tasks is to validate and standardize lipase assays for GL 
and PL, the two main digestive enzymes involved in triacylglycerols 
(TAG) digestion (Bakala N’Goma, Amara, Dridi, Jannin, & Carrière, 
2012). Briefly, TAG, are the main dietary lipids (~90%) in the human 
diet and GL and PL are the most important enzymes in TAG hydrolysis. 
A major difficulty in assaying the activity of these enzymes resides in 
the preparation of their substrate that is insoluble in water and forms a 
distinct liquid phase dispersed in water. Appropriate substrate emul-
sions have to be prepared to allow lipase adsorption and activity at the 
oil–water interface. This is essential because most lipases are activated 
at this interface by adapting their structure (lid opening) and access to 
their catalytic site (Mateos-Diaz et al., 2017). This is the main reason 
why many lipase assays with micellar or monomeric substrates rather 
than emulsions are not specific or sensitive enough for GL and PL ac-
tivity determination. This is the case with most chromogenic and fluo-
rogenic substrates that have been developed so far (Beisson, Tiss, 
Rivière, & Verger, 2000). In some assays with fluorescent or UV- 
absorbing (Beisson et al., 1999; Serveau-Avesque, Verger, Rodriguez, 
& Abousalham, 2013; Ulker et al., 2016), TAG substrates have been 
developed to allow high throughput assays using microtiter plates. They 
are adapted for studying purified enzymes but have not been validated 
with complex samples of digestion mixtures. Therefore, lipase assays 
using TAG emulsions are still the most specific and sensitive option. 
Sensitivity is due firstly to the high specific activities of lipases on 
emulsified TAG (several hundred to thousand international units (U) per 
mg of pure enzyme; 1 U = 1 µmole of fatty acid (FA) release per minute) 
and secondly, to the acid-base titration of the reaction products, i.e. FA, 
that can be performed using the pH-stat technique (Beisson et al., 2000). 
Various types of oils with short, medium and long chain FAs or their 
mixture can be used. Olive oil has been used as a reference substrate 
since decades, and it is recommended in most pharmacopeia assays of PL 
(see Pancrelipase and pancreatin monographs from European and 
United States Pharmacopeia (USP), (United States Pharmacopeia. 
(2018), 2018; European Pharmacopoeia, 2019)). Nevertheless, using 
long chain TAG as substrate requires the use of emulsifiers such as gum 
arabic to form a stable emulsion (Tiss, Carrière, & Verger, 2001). 
Moreover, long chain FAs have a pKa close to 7.6 (Benzonana, 1968; 
Bakala-N’Goma et al., 2015) and their full titration requires alkaline pH 
conditions. The USP pancrelipase assay is thus performed at pH 9, a pH 
value that is far different from the physiological conditions of the GI 
tract (Bakala N’Goma et al., 2012). Back-titration assays can be per-
formed with the release of FAs by the lipase at a physiological pH prior 
to FA full titration at pH 9, but these assays are time consuming and not 
as precise as the direct titration of FAs (Bakala-N’Goma et al., 2015). 
Because of all these drawbacks of long chain FA substrates, the use of a 
synthetic short chain oil, such as tributyrin, was introduced in 1970 by 
Erlanson and Borgström for the determination of lipase activity of 
pancreatic juice and small intestinal content (Erlanson & Borgstrom, 
1970). Using tributyrin has several advantages: i) it readily forms a fine 
emulsion under mechanical stirring and the addition of emulsifiers is not 
necessary; ii) butyric acid (pKa = 4.55) released from tributyrin can be 
directly titrated at the physiological pH of the small intestine and even at 
acidic pH found in gastric contents using a correction factor (Carrière, 
Barrowman, Verger, & Laugier, 1993); iii) the lipolysis products of 
tributyrin are soluble in water and do not accumulate at the oil–water 
interface like long chain lipolysis products that can subsequently inhibit 
lipase activity. Although some researchers were hesitant to use this non- 
natural substrate, tributyrin has progressively become a standard sub-
strate in many lipase assays, including GL assay, because it allows the 
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measurement of enzymatic activity at an acidic pH close to the optimum 
pH of activity (Gargouri et al., 1986; Carrière et al., 1993). This has 
made it possible to use a single reference substrate for both GL and PL 
adapted to and optimized for of the reaction conditions for each. GL is 
thus assayed in the presence of bile salts (2 mM sodium taurodeox-
ycholate (NaTDC)) and bovine serum albumin (BSA, 1.5 µM), whose 
roles are to decrease the interfacial tension at the tributyrin-water 
interface to avoid interfacial denaturation of the enzyme and thereby 
reach optimum conditions of activity (Gargouri, Piéroni, Lowe, Sarda, & 
Verger, 1986). PL activity is measured in the presence of a supramicellar 
concentration of bile salts (4 mM NaTDC) and of colipase, the specific PL 
cofactor that allows lipase anchoring at the oil–water interface in the 
presence of bile salts (Borgström, 1975). In both assays, the free fatty 
acids (FFAs) released upon tributyrin hydrolysis by the lipase can be 
titrated with sodium hydroxide (NaOH) using the pH-stat technique, i.e. 
the titration of FFAs at a constant pH value (5.5 for GL and 8 for PL). 
Besides lipase assays for the characterization of enzyme prepara-
tions, the pH-stat technique has also been used for measuring protein 
and lipid digestion in vitro (Beisson et al., 2000; Pinsirodom & Parkin, 
2001; Zangenberg, Mullertz, Kristensen, & Hovgaard, 2001; Gilham & 
Lehner, 2005; Li & McClements, 2010; Williams et al., 2012; Minekus 
et al., 2014; Chatzidaki, Mateos-Diaz, Leal-Calderon, Xenakis, & 
Carrière, 2016; Mat, Cattenoz, Souchon, Michon, & Le Feunteun, 2018; 
Mat, Souchon, Michon, & Le Feunteun, 2020). One has to be cautious, 
however, with the use of the pH-stat technique for these applications for 
the reasons previously mentioned (high pKa and poor titration of long 
chain FAs without back-titration) and also the strong buffering effects of 
some food components that can interfere with the titration. 
One of the advantages of implementing the pH-stat technique in a 
food digestion laboratory is that it permits the measurement of activities 
of other lipolytic enzymes such as pancreatic lipase-related protein 2 
(PLRP2), pancreatic carboxyl ester hydrolase (CEH) and pancreatic 
phospholipase A2 (sPLA2) using various lipid substrates from which FAs 
can be released and titrated (phospholipids, galactolipids, cholesterol 
and vitamin esters, synthetic esters) (Fernandez et al., 2008; Fernandez 
et al., 2010; Salhi et al., 2020). These assays are however not considered 
as part of this work. 
The main objectives of this multicentre study were: i) to test the 
repeatability and reproducibility of established GL and PL assays using 
the pH-stat technique; ii) to identify critical parameters for improving 
inter-laboratory variability; iii) to investigate the use of boronic acid as 
lipase inhibitor to block lipolysis. For this purpose, 21 laboratory 
members of the INFOGEST network involved in the WG4 group received 
three sources of lipases (one GL and two PLs) and measured their ac-
tivities following the same protocol but using different types of pH-stat 
equipment. 
2. Materials and methods 
2.1. Materials and equipment 
Trisaminomethane (Tris), sodium chloride (NaCl), calcium chloride 
(CaCl2⋅2H2O), NaTDC, NaOH, glyceryl tributyrate (tributyrin, ≥99%; 
#T8626 from Sigma-Aldrich), BSA (98%; #A7030 from Sigma-Aldrich), 
and 4-bromophenylboronic acid (#B75956 from Sigma-Aldrich) were 
purchased by each lab. 
Fig. 1 gives a schematic overview of the principle behind the pH-stat 
technique and of the different reaction vessel shapes as well as the 
stirring devices used by the 21 laboratories. To take part in this study, 
the participants were required to have at their disposal a pH-stat device 
equipped with a thermostated reaction vessel, a mechanical stirrer 
(propeller or magnetic stirrer), an automated system for 0.1 N NaOH 
delivery, and a pH electrode adapted for viscous/oily dispersions, 
ideally with a sleeve diaphragm. 
2.2. Lipase sources 
The 21 laboratories were supplied with three sources of lipases (one 
GL and two PLs), each from a single batch. Lyophilized RGE (#RGE25- 
100MG) were a generous gift from Lipolytech S.A. (Marseille, France) 
and contained 2.5% w/w of rabbit GL. One source of PL was porcine 
pancreatic extract (pancreatin) purchased from Sigma Aldrich (#P7545; 
8 × USP specification); this sample is referred to as Sigma pancreatin in 
the manuscript. Nordmark Arzneimittel GmbH & Co KG (Uetersen, 
Germany) provided the second source of PL, referred to as Nordmark 
pancreatin (#N0066397, lipase activity ≥ 80,000 Ph. Eur. U/g). Both 
pancreatin sources contained colipase, at a colipase to lipase molar ratio 
estimated at around 1.5 (Salhi et al., 2020), in other words a colipase 
amount that is sufficient to measure PL activity in the presence of bile 
salts without adding exogeneous colipase. 
2.3. Enzyme solution preparations 
Dispersion of each enzyme powder (1 mg/mL) was prepared by 
dissolving 10 mg of enzyme powder in 10 mL of cold ultrapure deionised 
water initially stored on ice, vortexed for 30 s and kept on ice until the 
assay was performed. 
The step-by-step protocol as communicated to the laboratories can 
be found in Supplementary Data (see Protocol for preparing enzymes stock 
solutions for lipase assays). 
It is worth noting that pancreatic extracts are not completely soluble 
in water and some enzyme activity (around 10%) remains associated to 
insoluble solid particles. We therefore recommended using this enzyme 
dispersion without prior filtration of the insoluble material and after 
homogenous mixing using a vortex. Also, it was requested to the par-
ticipants to perform the assay as soon as possible after preparing the 
enzyme solution since RGE and the pancreatin sources contain active 
proteases that can rapidly degrade the lipases, especially in pancreatin. 
Three different volumes (50, 100 and 200 µL) of each dispersion were 
used for the lipase assays, i.e. 50, 100 and 200 µg of enzyme preparation 
per assay. 
2.4. GL activity assay 
The assay solution (pH 5) in which the substrate (tributyrin) emul-
sion was formed contained 1.5 µM of BSA, 150 mM of NaCl and 2 mM of 
NaTDC, as optimized and described by Moreau et al. (Moreau, Gargouri, 
Lecat, Junien, & Verger, 1988) for rabbit GL and by Gargouri et al for 
human GL (Gargouri et al., 1986). The step-by-step protocol received by 
the laboratories can be found in the Supplementary Data (see Protocol for 
the assay of gastric lipase in RGE). The substrate emulsion was prepared 
directly in the pH-stat vessel thermostated at 37 ◦C while mixing 14.5 
mL of the assay solution and 0.5 mL of tributyrin. After the temperature 
was stabilized, the pH was adjusted to 5.5 and the pH-stat regulation 
started to keep this pH value constant. After recording the baseline and 
ensuring it was stable over time, the sample to be titrated (50, 100 or 
200 µL of the enzyme stock solution, or 100 µL of the enzyme-inhibitor 
solution (when GL inhibition is tested; see Section 2.7)) was added and 
NaOH (0.1 N) delivery was recorded as a function of time. 
Depending on the equipment used (regulation rate) and enzyme 
activity, the rate of NaOH delivery may not immediately progress line-
arly (presence of a lag time; Fig. 2) and therefore recording of NaOH 
delivery was recommended for at least 5 min. 
GL activity (AGL) was then estimated from the rate of NaOH delivery. 
Since butyric acid is not fully ionized and titrable at pH 5.5, a correction 
factor of 1.12 was applied to obtain the full activity from equation (Eq. 
(1)): 
AGL = (VNaOH/(t2 − t1)) × N × 1.12 (μmol/min) (1)  
where AGL is the rate of NaOH delivery in µmole per minute or enzyme 
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activity expressed in international units (U) (1 U = 1 µmol of butyric acid 
released per minute), VNaOH is the volume of NaOH delivered, in µL, 
between times t2 and t1 and N is the titre of NaOH (0.1 N). 
In a next step, the specific activity of RGE (SARGE) was calculated 
from Eq. (2): 
SARGE = (AGL × 1000)/(C × v) (U/mg) (2)  
where SARGE is expressed in U per mg of powder, C is the concentration 
(mg/mL) of powder in the enzyme solution and v is the volume of 
enzyme solution added in µL. 
To note: While biochemists usually express enzyme specific activity 
in IU per mg of proteins, it is a common practice to express activities of 
pharmaceutical enzyme preparations in IU per mass of material powder 
and these activities are the reference for further use of these 
preparations. Since protein amounts in commercial pancreatin prepa-
rations are rarely provided, it is more convenient to express specific 
activities in IU per mg for researchers performing in vitro digestion 
experiments. 
For each RGE concentration tested, three repeats were performed 
using a fresh preparation for each repeat. 
2.5. PL activity assay 
The assay conditions for the measurement of PL activity were iden-
tical to those described in the Supplementary Materials section of the 
INFOGEST protocol (Minekus et al., 2014; Brodkorb et al., 2019). They 
were based on the original work by Erlanson and Borgström (Erlanson & 
Borgstrom, 1970) who introduced the use of tributyrin as substrate for 
Fig. 1. Principle of lipase assay using the pH-stat technique. (A) Triacylglycerol (TAG) is the substrate of lipase (EC3.1.3.1 triacylglycerol hydrolase) that catalyses the 
release of free fatty acids (FFAs) from TAG. FFAs can be titrated by NaOH. (B) Schematic illustration of a pH-stat device, equipped with a thermostated reaction 
vessel, in which the substrate emulsion is formed by mechanical stirring; a pH-electrode connected to a pH-meter and a control unit for the automated delivery of 
NaOH by a burette. Every time the pH decreases due to the release of FFAs, NaOH is delivered to keep the pH constant at a pre-determined endpoint value. The 
delivery of NaOH (µmoles) is recorded as a function of time (min) and lipase activity is expressed in µmoles NaOH (or FFAs titrated) per min, with 1 international unit 
(U) equal to 1 µmol FFA/min. (C) Different geometries of reaction vessel (conical or cylindrical) and stirring devices (magnetic stirrer or propeller) available at the 
laboratories involved in the study. 
Fig. 2. Typical titration curves showing the 
delivery of NaOH (mL) as a function of time 
(min) in the course of a lipase assay with a 
pH-stat device. (A) Typical titration curve 
with a lag time showing the time period 
(around 5 min) during which the volume of 
NaOH delivered with time should be 
measured. (B) Assay of PL activity with 
increasing amounts of pancreatin (50, 100 
and 200 µg) showing the proportional in-
crease in NaOH delivery rate, as well as the 
reduced rate measured in presence of the in-
hibitor 4-bromophenyl boronic acid.   
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PL and have been established as standard conditions for measuring PL 
activity in complex mixtures such as pancreatin (Salhi et al., 2020) or 
intestinal contents (Carrière et al., 1993). The assay solution contained 
0.3 mM of Tris, 150 mM of NaCl, 2 mM of CaCl2, and 4 mM of NaTDC. 
The step-by-step protocol received by the laboratories can be found in 
Supplementary Data (see Protocol for the assay of pancreatic lipase in 
pancreatin). The substrate emulsion was prepared directly in the pH-stat 
vessel thermostated at 37 ◦C while mixing 14.5 mL of the assay solution 
and 0.5 mL of tributyrin. After the temperature was stabilized, the pH 
was adjusted to 8 and the pH-stat regulation started to keep this pH 
value constant. After recording the baseline and ensuring it was stable 
with time, the sample to be titrated (50 µL, 100 µL or 200 µL of the 
enzyme stock solution, or 100 µL of the enzyme-inhibitor solution (when 
PL inhibition is tested; see Section 2.7)) was added and NaOH (0.1 N) 
delivery was recorded as a function of time. 
PL activity (APL) was estimated from the rate of NaOH delivery. Since 
butyric acid is fully ionized at pH 8, no correction factor was required 
and activity was obtained from Eq. (3): 
APL = (ΔVNaOH/(t2 − t1)) × N (μmol/min) (3)  
where APL is the rate of NaOH delivery in µmoles per minute or enzyme 
activity expressed in international units (U) per milliliter (1 U = 1 µmol 
of butyric acid released per minute), VNaOH is the volume of NaOH 
delivered, in µL, between times t2 and t1 and N is the titre of NaOH (0.1 
N). 
Next, the specific activity of pancreatin (SAPancreatin) was calculated 
from Eq. (4): 
SApancreatin = (APL × 1000)/(C × v) (U/mg) (4)  
where SAPancreatin is expressed in U per mg of powder, C is the concen-
tration (mg/mL) of powder in the enzyme solution and v is the volume of 
enzyme solution added in µL. 
For each concentration of pancreatin (Sigma or Nordmark) tested, 
three repeats were performed using a fresh preparation for each repeat. 
2.6. Inhibition of GL and PL by boronic acid 
Lipase inhibition was performed by pre-mixing the RGE or the 
pancreatin sources with boronic acid. A solution of 4-bromophenylbor-
onic acid (1 M) was prepared in methanol (Williams et al., 2012) and 5 
µL of this stock solution was added to 1 mL of the enzyme stock solution 
at 1 mg powder per mL, prepared as described in Section 2.4. The 
mixture was vortexed and incubated at room temperature for 10 min 
before performing the assays of residual lipase activity as described in 
Sections 2.5 and 2.6. 
For the RGE, higher amounts of boronic acid were also tested using 
10, 25 and 50 µL of the 1 M stock solution. The assays, for each amount 
of boronic acid tested, and the negative control (methanol only) were 
performed in triplicate. 
To note: Efficient and full inhibition of purified lipases usually re-
quires the addition of surfactants like bile salts or lipids because they 
favour conformational changes giving inhibitor access to the lipase 
active site. However, it is not an absolute requirement with crude 
enzyme extracts in which lipases are mixed with other proteins and 
residual lipids. 
2.7. Statistical analysis 
The data of enzyme activity for the 3 sources of lipases were analysed 
using SPSS version 24.0 and the coefficients of variation (CVs) calcu-
lated. The International Council for Harmonisation of Technical Re-
quirements for Pharmaceuticals for Human Use (ICH) guidelines were 
used to define and assess the parameters of precision and evaluate the 
magnitude of variation among the activity assessment within and be-
tween labs (International Council for Harmonisation of Technical 
Requirements for Pharmaceuticals for Human Use, 2005). For all tests, 
the significance level was set at P < 0.05 (2 tailed). All data are 
expressed as means ± SD. Differences between enzyme preparation 
concentrations, for a same enzyme source, were analysed by Student’s 
paired t-test. 
For each enzyme preparation and concentration tested, 63 mea-
surements of lipase activity were performed (three replicates for 21 
laboratories) and analysed using the Shapiro-Wilk implementation in 
XLSTAT. Dixon test for outliers was performed on the average CV values 
for each set of 3 replicate measurements. Each laboratory was compared 
for the average CV of all replicates. Partial Least Squares (PLS) regres-
sion was used to determine the variables (vessel shape, burette volume, 
stirring mode, i.e. propeller or magnetic stirrer, and stirring speed) that 
have the most significant influence on the lipase activity (Tobias, 1995). 
For cross validation, the jackknife (leave-one-out; LOO) was used. The 
variables were centred and reduced prior to modelling. The variable 
importance for the projection (VIP) scores was determined from the 
following equation (5), according to Farrés et al. (Farrés, Platikanov, 







where wjf is the weight value for j variable and f component and SSYf is 
the sum of squares of explained variance for the fth component and J 
number of x variables. SSYtotal is the total sum of squares explained of the 
dependent variable and F is the total number of components. 
3. Results 
3.1. Overview of the equipment used 
Instruments from 8 different brands and/or models were used by the 
21 laboratories: Titrino (code 1; n = 3) and Titrando (code 2; n = 10) 
from Methrom, Mettler Toledo (code 3; n = 2), Radiometer Copenhagen 
Meterlab (code 4; n = 1), Kyoto Electronics Manufacturing (code 5; n =
2), Orion (code 6; n = 1), Dasgip Eppendorf (code 7; n = 1) and Cerko 
Lab System (code 8; n = 1). Conical reaction vessels (n = 14) were more 
widely found than cylindrical vessels (n = 7), and a magnetic stirrer (n 
= 14) more than a propeller (n = 7). Diversity was also observed in the 
maximum volume (ranging from 25 up to 200 mL) of the reaction vessel 
and the maximum volume (5, 10 or 20 mL) of the automated burette 
used for NaOH delivery. An automated burette works like a syringe with 
a piston. One laboratory (lab 16) used however a Dasgip Eppendorf 
bioreactor system instead of a classical pH-stat. This device had no 
burette and was based on a different principle (pump) for NaOH 
delivery. 
3.2. Specific activities of the lipase preparations 
The 21 laboratories involved measured the lipase activities, with 
tributyrin as a substrate, of a single batch of RGE as well as a single batch 
of each of the two different porcine pancreatin sources from Sigma and 
Nordmark, respectively. Assays were performed in triplicate using 3 
different amounts of enzyme preparation in each case. Only one labo-
ratory (lab 5) deviated from the average CV for all repeated replicates 
and was identified as a statistically significant outlier with the Dixon test 
having the highest mean CV of 14.2%. The values of this lab were 
therefore removed from the mean calculation and the data presented 
below. Table 1 shows the average (mean ± SD) of the specific activities 
obtained for each amount of enzyme preparation tested. For RGE and 
Sigma pancreatin the mean specific activities obtained for the three 
amounts tested (50, 100 and 200 µg) did not vary with the amount of 
enzyme (Fig. 3), which confirmed that these amounts of lipase were in 
the range allowed to measure a constant specific activity. This is a 
requirement for enzyme assays indicating that the substrate is in 
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sufficient excess to fully saturate enzyme active sites. Therefore, specific 
activities of GL in RGE and PL in Sigma pancreatin could be averaged 
from the three amounts tested and were 22.3 ± 7.1 (n = 63) and 65.9 ±
15.3 (n = 63) U/mg, respectively (Table S1 in Supplementary Data). 
These specific activities were slightly lower than those expected from 
the suppliers’ information which indicated 25 U/mg for RGE powder 
and between 80 and 240 U/mg for Sigma pancreatin (as deduced from 
USP units and the equivalence with units determined using tributyrin as 
substrate). 
For Nordmark pancreatin, the specific activities determined with 50 
and 100 µg of the enzyme preparation were both close to 140 U/mg 
(Table 1), but the specific activity measured with the third amount 
tested, i.e. 200 µg, was 1ower (124.8 ± 34.8 U/mg). This decrease in the 
specific activity at the highest concentration tested indicates that this 
amount was outside the range allowed for measuring a constant specific 
activity. Therefore, only the values obtained with the two lowest con-
centrations were considered for estimating the average specific activity 
of Nordmark pancreatin (140.9 U/mg, value obtained from data for 50 
and 100 µg only). This activity was 2.14-fold higher than the specific 
activity of the Sigma pancreatin, as expected from the information 
provided by the supplier. 
From the measured specific activities and the known specific activ-
ities of pure GL and PL (with tributyrin as a substrate), we could estimate 
how much active enzymes were present in the preparations (Table 2). 
The amount of GL in RGE was found to be 18.3 ± 6.0 µg/mg, while the 
amounts of PL in Sigma and Nordmark pancreatin sources were 8.2 ±
1.9 and 17.6 ± 3.7 µg/mg, respectively. We could thus estimate how 
much equivalents of pure enzymes were used in the assays when testing 
RGE (0.9–3.8 µg GL) and pancreatin sources (0.4 –3.5 µg PL). Since GL 
and PL have molecular masses of around 50 kDa and the reaction vol-
ume was 15 mL, the enzyme concentrations in the reaction vessel ranged 
from 1.2 to 5 nM for GL and from 0.6 to 4.7 nM for PL (Table 2). 
The intra-laboratory CVs were overall acceptable with mean values 
<10% (Table 1), regardless the enzyme source. On the other hand, the 
inter-laboratory variabilities were too large (>21%) to reach interna-
tional standards for bioanalytical method validation (see ICH M10 
guidelines as well as guidance for bioanalytical methods established by 
the Food and Drug Administration (Food and Drug Administration, 
2018) and the European Medicines Agency (European Medicines 
Agency, 2015), according to which CV values should not exceed 15%. 
The inter-laboratory variability was not reduced by removing data from 
the outlier laboratory. We therefore searched for the potential sources of 
variability among the laboratories involved. Since all laboratories were 
provided with the same detailed protocol, including the reagents to be 
used, and received lipase samples from the same batches, special 
attention was given to the various pH-stat devices that were used and 
their respective characteristics (see Table S2 in Supplementary Data). 
3.3. Search for pH-stat devices’ characteristics responsible for the 
variabilities observed 
All laboratories involved provided characteristics of the pH-stat de-
vice they used. Characteristics considered as variables in the following 
PLS analysis were: the maximum volume (mL) of the reaction vessel, the 
vessel shape (conical or cylindrical), the stirring mode (propeller vs 
magnetic stirrer), the stirring speed (rpm) and the maximum burette 
volume (mL) for the delivery of NaOH (except for one instrument for 
which NaOH delivery was not based on the use of a burette). 
PLS regression showed that certain experimental variables resulted 
in higher CVs than others (Fig. 4A). It could be seen that only two var-
iables had a VIP score larger than 1 (considered statistically significant), 
namely the conical and cylindrical shapes of the reaction vessel. Anal-
ysis of the contribution of each variable showed either a reduction or an 
increase of the CV for a particular laboratory (Fig. 4B). The conical 
vessel was associated with the lowest CV, whereas the cylindrical vessel 
conversely resulted in the highest CV. This may be attributed to a better 
mixing in the conical vessel. This mixing effect is also reflected in the 
effect of the volume of the vessel in which the assay was conducted. 
Indeed, a positive correlation between vessel volume and CV is shown in 
Fig. 4B, i.e. the larger the volume the larger the CV. Interestingly, a 
higher stirring speed also resulted in higher CVs, which may be due to 
changes in the emulsion droplets size and specific surface accessible for 
lipase adsorption and activity. A larger burette volume also resulted in a 
larger CV, probably because a larger volume of NaOH is delivered per 
actuated motion of the burette piston and regulation of titration is not as 
fine as with a smaller burette. The impact of the stirrer type was the least 
important. The instrument type was not included in the PLS analysis, 
assuming that all relevant instrument parameters were sufficiently 
covered by the variables previously mentioned. 
Besides the PLS analysis, we also plotted the variations in lipase 
specific activities of the three enzyme preparations as a function of the 
identified variables. Fig. 5 shows trends for the variables related to 
hydrodynamics of the reaction mixture, and thus the formation of the 
substrate emulsion. The highest specific activities were measured with 
the smallest reaction vessel volume (Fig. 5A) and the highest stirring 
rates (Fig. 5C), which is in agreement with the correlations deduced 
from the PLS regression. Concerning the vessel shape variables that were 
considered as the most influent according to PLS (Fig. 5B), no significant 
differences were observed between the mean values for all enzyme 
preparations (P < 0.001 for RGE, Sigma and Nordmark pancreatins). 
However, the most active enzyme preparation, Nordmark pancreatin, 
showed the highest (+8%) specific activity in the conical vessels. 
Dispersion of data (SD) around the mean was also reduced with conical 
vessels compared to cylindrical vessels and this was observed for all 
three enzyme preparations. Concerning the stirring mode, there was a 
tendency for measuring higher activities of RGE and Nordmark 
pancreatin with a propeller than with a magnetic stirrer (Fig. 5D), which 
was not highlighted by the PLS analysis. 
Fig. 6 displays the effect of the burette volume, with higher specific 
activities measured with the smallest burette volumes, especially for the 
Nordmark pancreatin. 
Table 1 
Specific activities (U/mg of powder) measured with various amounts of each 
lipase source with tributyrin as a substrate.  














50 22.3 ± 5.3 8 24 
100 22.0 ± 4.7 5 21 
200 22.6 ± 10.4 4 46 
All amounts 22.3 ± 7.1 5 32 
Sigma 
pancreatin 
50 66.0 ± 15.7 8 24 
100 65.1 ± 17.1 8 26 
200 66.5 ± 13.7 6 21 












50 + 100 140.9 ±
29.8 
5 21 
Values are means ± SD (n = 63; in triplicate by 21 laboratories for each amount 
tested) and coefficients of variation (CVs in %) were estimated for individual and 
for all laboratories involved. For complete data sets, see Tables S1 (data from 
individual laboratories with intra-laboratory CV%) and S2 (mean values for each 
enzyme preparation and amount for each laboratory, with inter-laboratory CV 
%) in Supplementary Data. 
* Constant specific activity in the linear range. 
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3.4. Inhibition of lipases by 4-bromophenylboronic acid (series 1, n = 21) 
All 21 laboratories were involved in a first series of inhibition assays 
performed with 100 µg of each enzyme preparation (after incubation 10 
min) with a fixed amount of inhibitor (Table 3). The specific activities of 
the two pancreatin sources were significantly reduced (P < 0.0001) 
when they were mixed with 4-bromophenylboronic acid, with only 8% 
and 6% of residual activity for Sigma and Nordmark pancreatins, 
respectively. On the other hand, 34% of gastric lipase from the RGE was 
still active when using the same quantity of the inhibitor. 
Inhibition assays of gastric lipase were therefore repeated with 
higher amounts of boronic acid (10, 25 and 50 µL of a 1 M solution) in a 
second series of experiments involving only 8 laboratories out of the 21 
(Table 4). This set of laboratories was based on their availability only. 
Fig. 3. Specific activities of the lipases sources as a function of the amount of enzyme preparation used in the assay. (A). Three different amounts (50, 100 and 200 µg) were 
tested for each enzyme preparation. (B) Representation of the same specific activities as a function of the pure enzyme equivalents (µg) present in these enzyme 
preparations. 
Table 2 
Estimation of active lipase amounts (µg/mg of powder) in RGE and pancreatins with tributyrin as a substrate.  
Enzyme source Amount of powder tested 
(µg) 
Specific activity (U/ 
mg)* 
Lipase amounts in the powder (µg/ 
mg) 
Lipase amounts in the assay 
(µg) 
Lipase concentration in the assay 
(nM) 
Lipolytech RGE 50 22.3 ± 5.4 18.6 ± 4.5 0.9 ± 0.1 1.2 
100 22.0 ± 4.8 18.3 ± 4.0 1.8 ± 0.1 2.4 
200 22.6 ± 10.5 18.8 ± 8.8 3.8 ± 0.2 5.0 
All amounts 22.3 ± 7.1 18.3 ± 6.0   
Sigma pancreatin 50 66.0 ± 15.8 8.3 ± 2.0 0.4 ± 0.1 0.6 
100 65.1 ± 17.2 8.1 ± 2.2 0.8 ± 0.1 1.1 
200 66.5 ± 13.8 8.3 ± 1.7 1.7 ± 0.1 2.2 
All amounts 65.9 ± 15.4 8.2 ± 1.9   
Nordmark 
pancreatin 
50 140.1 ± 30.3 17.5 ± 3.8 0.9 ± 0.5 1.2 
100 141.7 ± 30.2 17.7 ± 3.8 1.8 ± 0.5 2.4 
200 124.8 ± 34.9 out of range 3.5 ± 0.5 4.7 
50 + 100 140.9 ± 29.9 17.6 ± 3.7   
This estimation is based on the determination of specific activities (U/mg of powder) measured for each enzyme preparation and the known specific activities of rabbit 
GL (1200 U/mg of pure enzyme) (Moreau et al., 1988) and porcine PL (8000 U/mg of pure enzyme) (Tuvignon et al., 2008). 
* Constant specific activity in the linear range. 
Fig. 4. Variable importance for the projection 
(VIP). (A) Comparison of VIPs influencing 
the performance of the test. It can be seen 
that only one variable had a VIP larger than 1 
(considered statistically significant), namely 
the shape of the reactor vessel (conical and 
cylindrical). (B) Analysis of the contribution 
of each variable showing either a reduction 
of the coefficient of variation (CV) for a 
particular laboratory (typically vessels with 
conical shape) or an increase in the CV for a 
particular laboratory (typically vessels with 
cylindrical shape).   
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Addition of 50 µL of inhibitor solution, equivalent to an extremely high 
inhibitor to lipase molar ratio of 135,100 resulted in a residual activity 
of 12 ± 8%, which was still higher than the residual activities measured 
with the two pancreatin sources using a 10-fold lower inhibitor to lipase 
molar ratio of 13,500. 
3.5. Repetition of GL assay using RGE (series 2, n = 8) 
The second series of inhibition assays (n = 8) also repeated the assay 
of RGE specific activity using 100 µg of enzyme preparation as controls 
without the inhibitors (methanol only). These control assays were per-
formed in the presence of a small amount of methanol (5–50 µL), the 
solvent used for boronic acid solubilisation, added to the total reaction 
volume of 15 mL. The presence of methanol had no effect on the mean 
specific activity of RGE (Table 5). Therefore, this second series tested the 
repeatability and reproducibility of 100 µg RGE assay on two occasions 
for 8 laboratories. The number of repeats per laboratory was, however, 
higher in the second series (n = 12) than in the first series (n = 3) 
because 3 repeats were performed for each of the four inhibitor amounts 
tested. No significant difference was observed between the two series (P 
< 0.001). The mean intra-laboratory CV% was increased from 4 (first 
series, n = 21) to 10% (second series, n = 8) likely due to a higher 
number of repeats performed by each laboratory, but the repeatability 
remained acceptable (<15%). Interestingly, the inter-laboratory vari-
ability was much improved with a CV% of 10% in the second series 
versus 18% in the first series. In addition, this subgroup of 8 laboratories 
had already a better reproducibility than the whole group of 21 labo-
ratories (CV of 18 vs 21%) in the first series. The possible reasons for this 
improvement are analysed in the following discussion section. 
Fig. 5. Impact of pH-stat devices’ charac-
teristics on lipase activity measurement. 
This Figure illustrates the variations in 
lipase specific activities of the three 
enzyme preparations (RGE (50, 100 and 
200 µg), Sigma pancreatin (50, 100 and 
200 µg), and Nordmark pancreatin (50 
and 100 µg)) with several characteristic 
parameters of the pH-stat devices used in 
the various laboratories, namely (A) the 
reaction vessel maximum volume, (B) 
the vessel shape (conical or cylindrical), 
(C) the stirring rate, and (D) the stirrer 
type (propeller or magnetic stirrer). Each 
dot corresponds to the mean specific 
activity (n = 3) measured by one labo-
ratory for each amount of enzyme prep-
aration. In panels A and C, lines 
indicating the trends were obtained by 
linear regression.   
Fig. 6. Variations in lipase activities with the maximum volume of the burette for 
NaOH delivery. Each dot corresponds to the mean specific activity (n = 3) 
measured by one laboratory for each amount of enzyme preparation: 50, 100 
and 200 µg for RGE, 50, 100 and 200 µg for Sigma pancreatin, 50 and 100 µg for 
Nordmark pancreatin. Lines indicating the trends were obtained by 
linear regression. 
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4. Discussion 
4.1. GL and PL assays using tributyrin as substrate 
This study was performed to assess the repeatability and reproduc-
ibility of GL and PL assays that are recommended by the INFOGEST 
network to characterize lipase preparations prior to in vitro GI digestion 
studies. These assays were developed many years ago (Erlanson & 
Borgstrom, 1970; Gargouri et al., 1986; Moreau et al., 1988) and are 
considered as well optimized regarding reagents of the assay solution, 
temperature, pH and substrate. Tributyrin readily forms a fine emulsion 
upon mechanical stirring with a high specific surface area ensuring that 
all lipase molecules are adsorbed at the lipid-water interface and are 
available to form an enzyme-substrate complex. Indeed, lipase activity 
correlates with lipase adsorption (Benzonana & Desnuelle, 1965). A 
stationary state with a linear release of FFA over time is reached rapidly 
after launching the reaction (Fig. 2). Lipase assays with tributyrin are 
highly sensitive based on the high specific activities measured with 
purified lipases (1200 U/mg for rabbit (Moreau et al., 1988) and human 
(Gargouri et al., 1986) GL; 8000 U/mg for human and porcine PL 
(Tuvignon et al., 2008)) under optimized assay conditions. These spe-
cific activities can also be expressed as molecular turnover number or 
catalytic constant (kcat; mole of substrate hydrolysed per mole of enzyme 
per unit time), which gives values of 1000 and 6670 s− 1 for GL and PL, 
respectively, and places these enzymes in the upper range of all enzyme 
activities (Schomburg et al., 2017; Smejkal & Kakumanu, 2019). GL and 
PL assays with tributyrin have been used to characterise crude enzyme 
preparation (Sternby & Nilsson, 1997; Salhi et al., 2020) and purified 
enzymes (Borgström, 1975; Gargouri et al., 1986), as well as to assay 
lipase activities in biological samples collected from the GI tract (bi-
opsies (Moreau, Laugier, Gargouri, Ferrato, & Verger, 1988), digestive 
juices (Erlanson & Borgstrom, 1970; Ville, Carrière, Renou, & Laugier, 
2002), gastric and intestinal contents (Erlanson & Borgstrom, 1970; 
Carrière et al., 1993)). They have also been used for estimating GL and 
PL concentrations in GI tract contents and secretory outputs in the 
course of several clinical trials (Sternby, Nilsson, Melin, & Borgström, 
1991; Carrière et al., 1993; Borovicka et al., 1997; Carrière et al., 2001; 
Renou et al., 2001; Sternby, Hartmann, Borgstrom, & Nilsson, 2002; 
Carrière et al., 2005; Roman et al., 2007), because it is possible to 
convert enzyme activity (U/mL) into concentration of active enzyme 
(mg/mL), knowing the specific activity (U/mg) of pure enzymes. In 
some clinical studies, such as S245.2.003 (sponsored by Solvay Phar-
maceuticals GmbH), PL assay using tributyrin as substrate has been 
validated according to international guidelines for bioanalytical assays 
(ICH Guideline Q2A, Validation of Analytical Procedures: Definitions 
and Terminology, March 1995 and ICH Guideline Q2B, Validation of 
Analytical Procedures: Methodology, May 1997) and approved by the 
US Food and Drug Administration (Frédéric Carrière’s personal 
communication). The specificity and precision of the PL assays were 
therefore considered as acceptable, with definition of lower and upper 
limits of quantification. 
The use of both GL and PL assays have become more widely spread in 
recent years due to their recommendation in the protocols defined by the 
INFOGEST network (Minekus et al., 2014; Brodkorb et al., 2019). 
Because of this larger use, some discrepancies between laboratories have 
appeared, especially when identical batches of enzyme preparation were 
tested by different laboratories. It was therefore important to identify 
the variables that could explain these differences, although precise 
protocols describing the assay conditions had been provided (Minekus 
et al., 2014; Brodkorb et al., 2019). In laboratories familiar with pH-stat 
assays of lipase activities, it is well known that different results can be 
obtained using pH-stat devices from different brands/models. This is 
assumed to be caused by differences in reaction vessels (shape and 
volume) and stirring modes, because these parameters influence the 
formation of the substrate emulsion and thus, the specific surface 
Table 3 
Residual specific activities of the lipase sources mixed with 4-bromophenylboronic acid.  
Enzyme source Specific activity (U/mg)* Coefficient of variation (%) Residual activity (%) Inhibitor to lipase molar ratio 
Lipolytech RGE Control 22.0 ± 4.7 21 34 13,500 
Inhibitor 7.5 ± 0.9 12 
Sigma pancreatin Control 65.1 ± 17.1 26 8 30,300 
Inhibitor 5.5 ± 1.0 19 
Nordmark pancreatin Control 141.7 ± 30.1 21 6 14,300 
Inhibitor 8.9 ± 0.9 10 
Incubations were performed a room temperature for 10 min, after mixing 5 µL of a 4-bromophenylboronic acid solution (1 M) in methanol with 1 mL of the enzyme 
stock solution at 1 mg/mL. One hundred µL of this mixture was then used for measuring residual lipase activity. See the Result section for the estimation of the inhibitor 
to lipase molar ratio. Specific activity values (U/mg of powder) are means ± SD. The 21 laboratories were involved. See all individual data in Table S1 of Supple-
mentary Data. 
* Constant specific activity in the linear range. 
Table 4 
Residual specific activity (%) of the GL in RGE incubated with various amounts 














5 Control 19.5 ± 3.3 17 44 ± 11 13,500 
Inhibitor 8.4 ± 1.9 23 
10 Control 19.8 ± 3.8 19 33 ± 11 27,000 
Inhibitor 6.3 ± 1.9 29 
25 Control 19.3 ± 3.1 16 17 ± 7 67,500 
Inhibitor 3.1 ± 1.0 30 
50 Control 17.9 ± 3.5 20 12 ± 6 135,100 
Inhibitor 2.0 ± 1.1 54 
A 1 M solution of 4-bromophenylboronic acid was prepared in methanol and 5, 
10, 25 or 50 µL of this solution (5, 10, 25 or 50 µmoles) were mixed with 1 mL of 
RGE solution at 1 mg powder per mL (containing 18.3 µg or 0.37 nmoles of GL). 
Eight laboratories out of 21 were involved in this part of the study. See all in-
dividual data in Table S3 of Supplementary Data. 
* Constant specific activity in the linear range. 
Table 5 
Specific activity of 100 µg RGE (means ± SD) measured in two successive series 
by 8 laboratories.  






Series 1- All 
labs 
22.0 ± 4.7 5 21 
Series 1–8 
labs 
21.6 ± 3.9 4 18 
Series 2–8 
labs 
19.1 ± 3.1 10 10 
Numbers of assay repeats in each laboratory were n = 3 assays in series 1 and n 
= 12 assays in series 2. Coefficient of variations (CVs in %) were estimated for 
individual and for all laboratories involved. For complete data sets, see Tables S1 
and S3 in Supplementary Data. 
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available for lipase adsorption and activity at the oil–water interface. 
Some laboratories have, for instance, introduced correction factors to 
compare results obtained with different types of equipment or by 
different collaborators. This is not satisfactory since the result of an 
assay should not depend on the equipment utilised to be considered 
robust and widely applicable. A water-insoluble substrate, emulsified in 
the reaction vessel, can create this dependency and therefore, protocols 
should also include recommendations about the parameters of the pH- 
stat equipment to be used. This was the main objective of the ring 
trial described in this study and designed by the INFOGEST working 
group on lipid digestion and digestive lipases (WG4). 
4.2. Choosing the right amount of enzyme preparation for the assay 
Another potential source of variability in all enzyme assays are the 
respective quantities of enzyme and substrate used per assay. One has to 
check that these amounts fall within the range in which the activity is 
proportional to the amount of enzyme, i.e. constant specific activity. 
This is usually ensured by using a large excess of substrate versus 
enzyme to saturate enzyme active sites in the reaction. In this study, we 
used enzyme preparations containing micrograms of enzymes, and 
lipase concentrations in the assay reaction ranged from around 1 to 5 nM 
(Table 2). We used 0.5 mL of tributyrin as a substrate in a 15 mL reaction 
volume, which corresponds to an apparent concentration of 113 mM (if 
that substrate was not insoluble in water). Substrate to enzyme molar 
excess was very large and exceeded 107. Having such a high molar 
excess is however not always sufficient to ensure a constant specific 
activity of lipases in a large range of enzyme concentrations. Indeed, due 
to their peculiar mode of action involving enzyme adsorption at the 
lipid-water interface, the adsorption of various amounts of lipase can 
change the interfacial properties and thus lipase activity, as would do 
any surface active agent (Aloulou et al., 2006; Delorme et al., 2011) or 
other proteins present in complex enzyme preparations such as 
pancreatin and RGE. This is the reason why a linear relationship be-
tween the amount of lipase and lipase activity (or constant specific ac-
tivity) is usually observed in a very narrow range of concentrations 
when assaying lipases with an emulsified TAG substrate. For instance, a 
previous validation of the PL assay has shown that a constant specific 
activity could only be measured using 0.5–3.0 µg of pure PL (Frédéric 
Carrière’s personal communication). 
In the current work, we had preliminary information on lipase con-
tents in the pancreatin and RGE, and the laboratories involved in the 
ring trial were asked to perform assays with three different quantities of 
enzyme preparations (50, 100 or 200 µg) containing suitable amounts of 
lipases. This was confirmed by the 21 laboratories involved that ob-
tained consistent average specific activities of 22.3 and 65.9 U/mg for 
RGE and Sigma pancreatin, respectively, regardless the amount of 
enzyme preparation tested (Fig. 3 and Table 1). With Nordmark 
pancreatin, a highly active source of pancreatic enzymes used as an 
active pharmaceutical ingredient (API) in drug products for the treat-
ment of exocrine pancreatic insufficiency, the highest amount tested 
(200 µg) contained 3.5 µg of active PL and specific activity decreased 
(− 13%) compared to the specific activities estimated with 50 and 100 µg 
(Fig. 3). These assays have therefore confirmed the range of enzyme 
preparation amounts to be tested and demonstrated that using too much 
enzyme in the current assay conditions can result in an underestimation 
of the specific activity. This effect might be drastically amplified when 
using higher quantities of enzyme. When assaying the lipase activity of a 
new or unknown batch of enzyme preparation, we therefore recommend 
starting with 50 µg and then double the amount (100 µg) to check if the 
activity is doubled while having a constant specific activity. Following 
such a procedure will ensure further adaptation of assay conditions in 
the future if enzyme manufacturers are providing preparations with 
different lipase enrichments. 
4.3. Optimal pH-stat equipment parameters 
This study confirmed that the mixing conditions in the pH-stat vessel 
are critical to obtain accurate and reproducible lipase activities. This is 
influenced by the shape and size of the reaction vessel, the stirrer type 
and the stirring rate (Figs. 1, 4 and 5). Using a reaction vessel with a 
conical shape was the most important parameter influencing the inter- 
laboratory variability. In the second series of RGE assays involving 
only 8 laboratories out of the 21, most of these laboratories (7 out of 8) 
had a pH-stat instrument equipped with a conical vessel (see Table S4 of 
Supplementary Data) and reproducibility was improved compared to 
the first series of assays (Table 5). The maximum volume of the reaction 
vessel had a limited influence (Fig. 5A) but we recommend using a 
thermostated conical vessel with a 70 mL maximum capacity, which is a 
rather standard model on the market. The stirrer type (propeller vs 
magnetic bar) also had only a minor effect, although the highest activity 
of the most active enzyme preparation (Nordmark pancreatin) was 
recorded with the propeller (Fig. 5D). It is generally recommended to 
use a propeller because it allows a better monitoring of the stirring rate 
with viscous reaction mixtures. It does not seem to be the case here, but 
since the pH-stat equipment can also be used for running in vitro di-
gestions of various food systems, we still recommend the propeller as the 
best option. Specific activities were found to increase with the stirring 
rate (Fig. 5C) as intuitively expected. However, it is worth noting that 
the rates provided by the laboratories were often rough estimations of 
rates found in the instruction manuals. Indeed, most pH-stat instruments 
are equipped with stirrers having a few pre-set rates and it is not possible 
to finely adjust the stirring rate. If possible, we would recommend using 
a stirring rate between 700 and 800 rpm, a range in which the specific 
activities measured with pancreatins are close to the mean specific ac-
tivities measured by all laboratories (Fig. 5C). The last variable of 
importance was the volume of the burette used for the automated de-
livery of NaOH, with higher specific activities recorded with the smallest 
burettes (Fig. 6). We assume this is due to the precision of NaOH delivery 
to keep the pH of the system at the set value (pH 5.5 for GL and pH 8 for 
PL), the smallest burettes being the most precise at adding small vol-
umes of NaOH into the reaction vessel. In this ring trial, the smallest 
burettes had a volume of 5 mL and we recommend using this volume 
although smaller burettes of 2 mL would be even better, as for instance 
with the old pH-stat instruments manufactured by Radiometer (TTT80). 
Indeed, the latest generation of pH-stat equipment on the market may 
not be the most appropriate instruments for measuring lipase activities. 
These instruments have been developed for classical acid/base titration 
and not enzyme assays during which the rate of acid release varies with 
enzyme activity. Ideally, it should be possible to adjust the rate of NaOH 
delivery in the course of the titration, which is necessary for systems 
having lag times or changes in enzyme activity in the course of the re-
actions such as when testing lipase inhibitors. 
In conclusion, it is recommended to use a pH-stat device equipped 
with a conical vessel of 70 mL maximal capacity, a propeller stirrer 
(stirring rate between 700 and 800 rpm) and a burette of 5 mL for NaOH 
delivery. 
4.4. The lipase inhibitor 4-bromophenyl boronic acid is not an efficient 
inhibitor of GL 
Boronic acids were shown to be PL inhibitors by Guarner in 1980 
(Garner, 1980). More recently, 4-bromophenyl boronic acid was chosen 
as PL inhibitor to stop lipolysis in samples collected from the digestion of 
lipid-based formulations (Williams et al., 2012). This blocks lipolysis at 
given times during digestion prior to the analysis of lipolysis products 
and avoids the evolution of these products into other lipase substrates 
like diacyl- and monoacylglycerols. By analogy, it was proposed to use 
this inhibitor and a similar protocol to stop lipolysis in samples collected 
from food digestion by PL. We confirmed here that 4-bromophenyl 
boronic acid significantly inhibits PL present in Sigma and Nordmark 
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pancreatins, with low residual activities of 6–8% after 10 min of incu-
bation with an inhibitor to lipase molar ratio of at least 14,300 (Table 3). 
For the sake of comparison, a similar inhibition of porcine PL by the 
lipase inhibitor Orlistat (also called tetrahydrolipstatin; THL) is ach-
ieved using an inhibitor to lipase molar ratio of 10,000 (Gargouri, 
Chahinian, Moreau, Ransac, & Verger, 1991). Inhibition of PL by THL 
was however shown to be reversible during the assay of residual PL 
activity (Tiss, Lengsfeld, Carrière, & Verger, 2009) and therefore 4-bro-
mophenyl boronic acid is currently recommended for blocking lipolysis 
in samples containing PL. 
While THL also acts as an inhibitor of GL, there was no report in the 
literature that 4-bromophenyl boronic acid could also inhibit GL. We 
therefore tested the inhibition of GL present in RGE using the same 
protocol as for PL in pancreatin. An inhibitor to lipase molar ratio of 
13,500 was first used, leading to a high residual activity of 34% 
(Table 3). Even after increasing the inhibitor to lipase molar ratio up to 
135,100, residual GL activity remained high (12 ± 6%; Table 4 and 
Fig. 7A). 4-Bromophenyl boronic is therefore a weak inhibitor of GL, 
especially compared to THL that fully blocks GL from RGE at an inhib-
itor to lipase molar ratio of 2,000 (Fig. 7B) (Gargouri et al., 1991). Half- 
inhibition of GL is achieved with inhibitor to lipase molar ratio of around 
10,000 with 4-bromophenyl boronic compared to approximately 300 
with THL. 
In conclusion, it is not recommended to use 4-bromophenyl boronic 
for GL inhibition but rather THL, an inhibitor very efficient in blocking 
gastric lipase and intragastric lipolysis (Carrière et al., 2001). 
5. Conclusion 
The step-by-step detailed protocols for GL and PL activity assays 
provided to the laboratories involved in this ring trial allowed each 
laboratory to precisely assess the specific activities of enzyme prepara-
tion with a good repeatability. Further recommendations were required 
concerning the characteristics of the pH-stat instruments in order to 
improve the reproducibility of the assays among the laboratories 
involved. These suggestions are now available, especially concerning 
the type of reaction vessel (conical with a maximal capacity of 70 mL) to 
be used, and as a consequence a better reproducibility was observed in 
the second series of experiments. In addition, it is recommended to use 
4-bromophenyl boronic for PL inhibition, however, for GL inhibition 
THL should be used. The results of this study improve the GL and PL 
assays associated with the INFOGEST protocols of in vitro GI digestion 
(Minekus et al., 2014; Brodkorb et al., 2019; Mulet-Cabero et al., 2020). 
Before running an in vitro lipid digestion, lipase activities have to be 
verified for each new batch of digestive enzyme preparation, or if the 
source has been stored for an extended period of time, to ensure the 
targeted activity is reached. The new recommendations presented here 
will contribute to a better quality control of enzyme preparations. 
6. Ethics statements 
The research did not include any human subjects and animal 
experiments. 
CRediT authorship contribution statement 
Myriam M.L. Grundy: Conceptualization, Methodology, Data 
curation, Formal analysis, Writing - original draft, Writing - review & 
editing, Supervision, Project administration. Evan Abrahamse: Inves-
tigation, Data curation, Formal analysis, Writing - review & editing. 
Annette Almgren: Investigation, Data curation, Formal analysis, 
Writing - review & editing. Marie Alminger: Investigation, Data cura-
tion, Formal analysis, Writing - review & editing. Ana Andres: Inves-
tigation, Data curation, Formal analysis, Writing - review & editing. 
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